Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Avidity Biosciences (RNA) Gross Profit: 2018-2024

Historic Gross Profit for Avidity Biosciences (RNA) over the last 7 years, with Dec 2024 value amounting to $10.9 million.

  • Avidity Biosciences' Gross Profit rose 434.03% to $12.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.9 million, marking a year-over-year increase of 106.27%. This contributed to the annual value of $10.9 million for FY2024, which is 13.99% up from last year.
  • Avidity Biosciences' Gross Profit amounted to $10.9 million in FY2024, which was up 13.99% from $9.6 million recorded in FY2023.
  • Avidity Biosciences' 5-year Gross Profit high stood at $10.9 million for FY2024, and its period low was $6.8 million during FY2020.
  • For the 3-year period, Avidity Biosciences' Gross Profit averaged around $9.9 million, with its median value being $9.6 million (2023).
  • Its Gross Profit has fluctuated over the past 5 years, first skyrocketed by 192.67% in 2020, then decreased by 1.09% in 2022.
  • Avidity Biosciences' Gross Profit (Yearly) stood at $6.8 million in 2020, then spiked by 37.41% to $9.3 million in 2021, then fell by 1.09% to $9.2 million in 2022, then grew by 3.64% to $9.6 million in 2023, then rose by 13.99% to $10.9 million in 2024.